* Rapid Micro Biosystems Inc RPID.OQ reported a quarterly
adjusted loss of 31 cents per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of -32 cents. The mean expectation of
three analysts for the quarter was for a loss of 29 cents per
share. Wall Street expected results to range from -30 cents
to -28 cents per share.
* Revenue rose 11.4% to $5.61 million from a year ago;
analysts
expected $5.50 million.
* Rapid Micro Biosystems Inc's reported EPS for the quarter
was a
loss of 31 cents.
* The company reported a quarterly loss of $13.32 million.
* Rapid Micro Biosystems Inc shares had risen by 2.1% this
quarter and gained 33.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 3.3%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Rapid Micro
Biosystems Inc is $5.25
This summary was machine generated from LSEG data May 3 at 03:13
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.29 -0.31 Missed
Dec. 31 2023 -0.30 -0.26 Beat
Sep. 30 2023 -0.31 -0.31 Met
Jun. 30 2023 -0.35 -0.33 Beat